Menetrier's disease therapy: rebooting mucosal signaling.
Ménétrier's disease, a rare hyperproliferative disorder of the stomach, is associated with chronic abdominal pain, vomiting, weight loss, and edema, as well as an increased risk of gastric cancer. Therapy, other than surgical resection of the stomach, is limited to supportive measures and reflects the limited understanding of Ménétrier's disease pathogenesis. Data reported in this issue describe a promising targeted therapeutic approach and provide new insight into the causes of Ménétrier's disease.
Nalle
Sam C
SC
Department of Pathology, University of Chicago, Chicago, IL, USA.
Turner
Jerrold R
JR
D000328:Adult; D000818:Animals; D002415:Cats; D066246:ErbB Receptors / Q000378:metabolism; D005753:Gastric Mucosa / Q000378:metabolism*; D005758:Gastritis, Hypertrophic / Q000378:metabolism / Q000628:therapy*; D006801:Humans; D015398:Signal Transduction
D066246:ErbB Receptors